SpyGlass Pharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $115.9M
Liabilities Breakdown FY2025
Total Liabilities: $10.2M
Asset Breakdown
Total Assets: $115.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $96.4M | 83.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.3M | 2.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $17.2M | 14.8% |
Liabilities Breakdown
Total Liabilities: $10.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.7M | 26.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $7.5M | 73.5% |